Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes

Authors:

Abstract
Conflicting evidence exists on the efficacy and safety of bivalirudin administered as part of percutaneous coronary intervention (PCI) in patients with an acute coronary syndrome.

This publication has 22 references indexed in Scilit: